Eilly Mounjaro® Injection Submits Registration Application in China
Eilly announced that the company has officially submitted Mounjaro® (tirzepatide) injection to the National Drug Administration Drug Review Center (CDE) for improvement on dietary control and exercise Registration application for blood sugar control in adult patients with type 2 diabetes (T2DM). Mounjaro® is a weekly injected glucose-dependent insulin polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.
More hot information, insight analysis, research reports, live lectures... Please pay attention to [Hard Technology]
Welcome to search for [Hard Technology] on major platforms and identify the account of the blue logo!
Advanced financial services for millions of "hard technology" enterprises in China to create a better future together! We focus on industries such as optoelectronic chips, artificial intelligence , aerospace, new energy, smart cars, biomedicine , science and technology innovation finance, and rely on the unique scientific and technological intelligence data owned by smart art , scientific and technological innovation intelligence service provider smart art Advantages: See technological trends with readers, understand the hard technology industry, and connect with the future of innovation. "Hard Technology" is produced by the Smart Yao Innovation Research Center.
